Subsense, a neurotechnology company developing the first non-surgical, nanoparticle-based Brain-Computer Interface (BCI), emerged from stealth today to formally reveal its efforts in the emerging field of non-invasive brain connectivity. Co-founded by neurotech entrepreneur Tetiana Aleksandrova and serial entrepreneur Artem Sokolov, Subsense has raised $17M in seed funding led by Sokolov's Golden Falcon Capital to accelerate the development of bidirectional nanoparticle-based technologies that connect the human brain with external sources. Subsense is working with a consortium of leading international neurological research institutions which include UC Santa Cruz and ETH Zurich, Switzerland's Federal Institute of Technology.

Subsense is a neurotechnology company developing the first non-surgical, nanoparticle-based bidirectional brain-computer interface. Subsense is partnered with leading global neurological research institutions.